Background. Few studies have specifically observed the relationship of sarcopenia, visceral
obesity, or their joint effects with lean NAFLD in patients with diabetes. We aimed to …

Aims Recent epidemiological studies have suggested an association between sarcopenia
and non-alcoholic fatty liver disease (NAFLD) in the general population, prompting our …

Background & aims Non-alcoholic fatty liver disease (NAFLD) is significantly related to
sarcopenia as well as obesity and its associated comorbidities. This cross-sectional study …

Background The association between nonalcoholic fatty liver disease (NAFLD) and
sarcopenia has been suggested. We investigated the association between sarcopenia and …

Methods In total, 2,191 subjects completed a health checkup program, including abdominal
ultrasonography and FibroScan. Subjects were classified into the following four categories …

Nonalcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver
diseases in the world. The risk factor for NAFLD is often considered to be obesity, but it can …

Background Sarcopenic obesity, central obesity combined with decreased skeletal muscle
mass, is identified to be associated with metabolic syndrome and cardiovascular diseases; …

Background Currently, both non-alcoholic fatty liver disease (NAFLD) and sarcopenia have
attracted extensive attention in public health. However, the relationship between NAFLD and …

There is exponential interest in non-alcoholic fatty liver disease (NAFLD) as a cause of
chronic liver disease in the last decade [1]. The epidemic of obesity due to changes in life …

Although the association of nonalcoholic fatty liver disease (NAFLD) with obesity or
sarcopenia is known, few studies have investigated the combined effect of various body …